Xiaoxuan Xing

Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis

Li Yang, Xian‐Zhe Dong, Xiaoxuan Xing et al. · World Journal of Gastrointestinal Oncology · 2020 · 27 citations · Full text

Medicine, Immunology, Oncology +16

Cost-Effectiveness Analysis of Camrelizumab Plus Chemotherapy vs. Chemotherapy Alone as the First-Line Treatment in Patients With IIIB–IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Without EGFR and ALK Alteration from a Perspective of Health - Care System in China

Chen Zhu, Xiaoxuan Xing, Bin Wu et al. · Frontiers in Pharmacology · 2021 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database

Xiaoxuan Xing, Xiaotong Zhang, Ke Wang et al. · Alzheimer s Research & Therapy · 2025 · 26 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Development of a list of high-risk perioperative medications for the elderly: a Delphi method

Ke Wang, Jianghua Shen, Dechun Jiang et al. · Expert Opinion on Drug Safety · 2019 · 16 citations

Pharmacy, Geriatric Medicine, Perioperative Medicine +16